Leukemia Research
Volume 29, Issue 8 , Pages 859-861 , August 2005

Multiple effects of Bioflavonoids on gene regulation, cell proliferation and apoptosis: Natural compounds move into the lime light of cancer research

Received 4 January 2005

References 

  1. Rusznyák S, Szent-Györgyi A. Vitamin nature of flavones. Nature. 1936;138:798
  2. Cody V. Crystal and molecular structures of flavonoids. Prog Clin Biol Res. 1988;280:29
  3. Noroozi M, Angerson WJ, Lean ME. Effects of flavonoids and Vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr. 1998;67:1210
  4. Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr. 1998;68:1418S
  5. Adlercreutz H, Mazur W. Phyto-oestrogens and western diseases. Ann. Med. 1997;29:95
  6. Mallikarjuna G, Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R. Silibinin prevent photocarcinogenesis, which involves the inhibition of DNA synthesis, cell proliferation, and cell cycle progression and an induction of apoptosis. Cancer Res. 2004;64:6349
  7. Smith DM, Daniel KG, Wang Z, Guida WC, Chan TH, Dou QP. Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design. Proteins. 2004;54:58
  8. Naasani I, Oh-Hashi F, Oh-Hara T, Feng WY, Johnston J, Chan K, et al. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 2003;15:824
  9. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci. 2000;97:4790
  10. Glossmann H, Presek P, Eigenbrodt E. Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-independent, transforming protein kinase, pp60src. Naunyn Schmiedebergs Arch Pharmacol. 1981;317:100
  11. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 1992;52:6200
  12. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 1994;54:4952
  13. Matsui J, Kiyokawa N, Takenouchi H, Taguchi T, Suzuke K, et al. Dietary bioflavonoids induce apoptosis in human leukemia cells. Leuk Res. 2005;29:573
  14. Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004;25:647
  15. Brusselmans K, Vrolix R, Verhoeven G, Swinnen JV. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem. 2005;280:5636
  16. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther. 2001;90:157
  17. Moyers SB, Kumar NB. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev. 2004;62:204
  18. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 1997;350:990
  19. Stoll BA. Eating to beat breast cancer: potential role for soy supplements. Ann Oncol. 1997;8:223
  20. Shen F, Xue X, Weber G. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Res. 1999;19:1657
  21. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998;89:254
  22. Bible KC, Bible RH, Kottke TJ, Svingen PA, Xu K, Pang YP, et al. Flavopiridol binds to duplex DNA. Cancer Res. 2000;60:2419
  23. Senderowicz AM. Small-molecule cyclin-dependent kinase modulators. Oncogene. 2003;22:6609
  24. Ferry DR, Smith A, Malkhandi J, Fyfe DW, de Takats PG, Anderson D, et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996;2:659
  25. Ferry DR, Anderson M, Beddows K, Mayer P, Price L, Jankowski J. Phase II trial of gefitinib (ZD1839) in advanced adenocarcinoma of the oesophagus incorporating biopsy before and after gefitinib. 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), J Clin Oncol 2004;22(14S):4021.
  26. Ravindranath MH, Muthugounder S, Presser N, Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol. 2004;546:121
  27. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukaemia. Blood. 2004;104:788
  28. Richardson MA. Research of complementary/alternative medicine therapies in oncology: promising but challenging. J Clin Oncol. 1999;17:38
  29. Boersma BJ, Barnes S, Kirk M, Wang CC, Smith M, Kim H, et al. Soy isoflavonoids and cancer—metabolism at the target site. Mutat Res. 2001;480-481:121
  30. Rowley J, Olney HJ. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosomes Cancer. 2002;33:331

☆ This editorial is linked to the article by Matsui et al. Dietary bioflavonoids induce apoptosis in human leukemia cells. Leuk Res 2005;29(5):573–82.

PII: S0145-2126(05)00196-7

doi: 10.1016/j.leukres.2005.01.022

Leukemia Research
Volume 29, Issue 8 , Pages 859-861 , August 2005

Article Tools